https://www.selleckchem.com/products/fhd-609.html
surgical audits. Ninety-day hospital readmission rates following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) range from 20 to 40%. The aim of this study was to develop and validate a simple score to predict readmissions following CRS/HIPEC. Using a prospectively maintained database, we retrospectively reviewed clinicopathologic, perioperative, and day-of-discharge data for patients undergoing CRS/HIPEC for peritoneal surface malignancies between 2010 and 2018. In-hospital mortalities and discharges to
إعجاب
علق
شارك
